• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Sirtex Medical Ltd

+ Add to Watchlist

SQX:GR

10.343 EUR 0.059 0.57%

As of 02:20:00 ET on 04/17/2014.

Snapshot for Sirtex Medical Ltd (SQX)

Open: 10.343 Day's Range: 10.343 - 10.343 Volume: 0
Previous Close: 10.402 52wk Range: 7.090 - 10.750 1-Yr Rtn: +33.43%

Stock Chart for SQX

No chart data available.
  • SQX:GR 10.343
  • 1D
  • 1M
  • 1Y
10.402
Interactive SQX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SQX

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 36.1992
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) 0.4230
Est. PEG Ratio 1.1753
Market Cap (M EUR) 580.33
Shares Outstanding (M) 56.11
30 Day Average Volume 1
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.15%
Cash Dividend (AUD) 0.1200
Dividend Ex-Date 10/04/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SQX

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for SQX

Sirtex Medical Limited is a medical company which researches, develops and commercializes medical products for the treatment of liver cancer. The Company is based in Western Australia and markets its products throughout the world. The Company's products include "SIR-Spheres," which uses micro-particle technology to treat liver cancer.

Gilman WongManaging Director/CEODarren SmithCFO/Secretary
David CadeChief Medical OfficerMichael ManganoPresident:US
More Company Profile & Key Executives for SQX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil